| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 01/25/2005 | CA2231201C Toilet bowl cleaning tablet |
| 01/20/2005 | WO2005005394A2 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 01/20/2005 | WO2005005388A1 Hydrogen peroxide catalyzed process for the preparation of sterically hindered n-hydrocarbyloxyamines |
| 01/20/2005 | WO2005005345A2 Use of functionalized onium salts as a soluble support for organic synthesis |
| 01/20/2005 | WO2005004866A1 Therapeutic agents useful for treating pain |
| 01/20/2005 | WO2005004810A2 Arylsulfonamide derivatives |
| 01/20/2005 | WO2005004803A2 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/20/2005 | WO2004106411A3 Biodegradable poly(beta-amino esters) and uses thereof |
| 01/20/2005 | WO2004089926A8 Genipin derivatives and uses thereof |
| 01/20/2005 | WO2004083208A8 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 01/20/2005 | WO2004069793A3 Novel 2-substituted cyclic amines as calcium sensing receptor modulators |
| 01/20/2005 | US20050014948 Using amine n-oxyl compound; heat and light stabilizers |
| 01/20/2005 | US20050014946 Substituted amino ketone compounds |
| 01/20/2005 | US20050014941 Cyanoalkylamino derivatives as protease inhibitors |
| 01/20/2005 | US20050014840 Thiol sulfonamide metalloprotease inhibitors |
| 01/20/2005 | US20050014795 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/20/2005 | US20050014794 For therapy and prophylaxis of anorexia, cancer cachexia, eating disorders, age-related decline in body composition, weight gain, obesity, and diabetes mellitus |
| 01/20/2005 | US20050014793 Pyridinone derivatives for treatment of atherosclerosis |
| 01/20/2005 | US20050014791 Inhibitors of papilloma virus |
| 01/20/2005 | US20050014790 Processes and intermediates for resolving piperidyl acetamide stereoisomers |
| 01/20/2005 | US20050014789 Psychological disorderas; antidepressants; obsessive complusive disorders; drug abuse; |
| 01/20/2005 | US20050014788 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/20/2005 | US20050014787 5-amidino-2-hydroxybenzenesulfonamide derivatives medicinal compoistions containing the same medicinal use thereof and intermediates in the production thereof |
| 01/20/2005 | US20050014757 Serotonin receptor antagonist; psychological disorders; side effect reduction |
| 01/20/2005 | US20050014740 E.g. 4-[2-(4-Methylphenoxy)- or 4-[2-(4-Methylphenylsulfanyl)-phenyl]-3,6-dihydro-2H-pyridine or piperazine or hydrochloride or oxalate; treating depression, anxiety, and obsessive compulsive disorders |
| 01/20/2005 | US20050014728 Therapy or prevention of diseases caused by lymphocyte interaction; antiinflamamtory agents; autoimmune disease |
| 01/20/2005 | US20050014724 Immunosuppressant compounds and compositions |
| 01/20/2005 | US20050014702 Inhibition of pdf enzyme as bactericidal agents for veterinary medicines |
| 01/20/2005 | CA2531787A1 Sulfonamide derivatives as 5ht7 receptor antagonists |
| 01/20/2005 | CA2530538A1 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 01/20/2005 | CA2530006A1 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/20/2005 | CA2529739A1 Aspartyl protease inhibitors |
| 01/19/2005 | EP1498411A1 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 01/19/2005 | EP1497300A2 Plasma carboxypeptidase b inhibitors |
| 01/19/2005 | EP1497274A2 Terphenyl derivatives, preparation thereof, compositions containing same |
| 01/19/2005 | EP1497273A2 Hydroxamic acid derivatives |
| 01/19/2005 | EP1497268A2 Nitric oxide donors, compositions and methods of use |
| 01/19/2005 | EP1497265A1 Compounds having affinity at 5ht2c receptor and use thereof in therapy |
| 01/19/2005 | EP1497260A1 Novel methoxybenzamide compounds for use in mch receptor related disorders |
| 01/19/2005 | EP1497256A1 Substituted 1,5-diaminopentan-3-ol compounds |
| 01/19/2005 | EP1497245A1 PROCESS FOR THE PREPARATION OF NONRACEMIC SYN-1-(4-HYDROXY-PHENYL)-2-(4-HYDROXY-4-PHENYL.PIPERIDIN-1Yl)-1-PROPANOL COMPOUNDS |
| 01/19/2005 | EP1496901A2 Compositions comprising mmp7 modulators for the treatment of chronic pain |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/19/2005 | EP1480952A4 Process for the synthesis of 2,2,6,6-tetramethyl-4-oxopiperidine |
| 01/19/2005 | EP1395574B1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 01/19/2005 | EP1294657B1 Catalysis using phosphine oxide and sulfoxide compounds |
| 01/19/2005 | EP1181271B1 Naphthalene ureas as glucose uptake enhancers |
| 01/19/2005 | EP0777492B1 Combinatorial libraries of substrate-bound cyclic organic compounds |
| 01/19/2005 | CN1568313A Piperidine compounds as muscarinic antagonists |
| 01/19/2005 | CN1568312A Biphenylcarboxamides useful as lipid lowering agents |
| 01/19/2005 | CN1566065A Alpha position heteroatom substituted gamma aryl ketobutyric acid derivative, process, pharmaceutical combination and uses thereof |
| 01/19/2005 | CN1185228C Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
| 01/19/2005 | CN1185227C Novel compounds |
| 01/19/2005 | CN1185223C Novel Compounds and methods for synthesis and therapy |
| 01/19/2005 | CN1185215C Substituted glutarimides and use as IL-12 production inhibitors thereof |
| 01/19/2005 | CN1185211C Benzamide derivatives for the treatment of diseases resulted from cytokines |
| 01/18/2005 | US6844440 Hydrolysis and decarboxylation of 1-alkyl- or aralkyl-4-((2-hydrocarbyloxycarbonyl-5,6-dimethoxyindan-1-one)-2 -yl)methylpiperidine |
| 01/13/2005 | WO2005003092A1 Preparation of intermediates for acetyl cholinesterase inhibitors |
| 01/13/2005 | WO2005003090A1 1- (alkylaminoalkyl-pyrolidin-/piperidinyl) -2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists |
| 01/13/2005 | WO2004082623A3 Substituted piperidine compounds |
| 01/13/2005 | WO2004064764A3 Substituted alkyl amido piperidines |
| 01/13/2005 | US20050010052 P2X7 receptor (a ligand-gated ion channel) antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases; osteoarthritis |
| 01/13/2005 | US20050010051 catalytically hydrogenating 4-[1-hydroxy-1-(2,3-dimethoxyphenyl)methyl]pyridine to provide 4-[1-hydroxy-1-(2,3-dimethoxyphenyl)methyl]piperidine, which is reacted with 4-fluorophenylacetylating reagent in the presence of base/solvent |
| 01/13/2005 | US20050009906 e.g., N-{4-[3-(4-Hydroxy-piperidin-1-yl)-3-oxo-propoxy]-cyclohexyl}-N-methyl-4-trifluoromethyl-benzenesulfonamide and p-chlorophenyl methyl-(2-{4-[methyl-(2-methylcarbamoyl-ethyl)-carbamoyl]-cyclohexyl}-ethyl)-carbamate |
| 01/13/2005 | US20050009887 Method of resolving amlodipine racemate |
| 01/13/2005 | US20050009886 4-[[3-([methoxyphenoxy)ethylamino]-2-hydroxypropoxy]-substituted phenyl]-1,4-dihydropyridine--2,6-dimethyl-3,5-dicarboxylic acids, esters and acyl halides; these compounds block an alpha -, beta -adrenoreceptor or calcium channel, inducing hypotension or vaso-relaxation |
| 01/13/2005 | US20050009871 Ubiquitin ligase inhibitors |
| 01/13/2005 | US20050009840 2-amino- pyridines and pyrazines additionally substituted witn one or more carbocyclic or heterocyclic groups, e.g., 4-[6-amino-5-(2,6-dichloro-benzyloxy)-pyridin-3-yl]-phenol, for treating many kinds of cancer |
| 01/13/2005 | US20050009838 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/13/2005 | US20050009814 Pharmaceutical composition containing gabapentin or pregabalin and N-type calcium channel antagonist |
| 01/13/2005 | US20050009786 Immunosuppressant compounds and compositions |
| 01/13/2005 | US20050009730 Sleep disorders; side effect reduction |
| 01/13/2005 | CA2525801A1 1- (alkylaminoalkyl-pyrolidin-/piperidinyl) -2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists |
| 01/12/2005 | EP1495002A1 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/12/2005 | EP1495001A1 Antibacterial agents |
| 01/12/2005 | EP1495000A1 Alpha, omega-dicarboximide derivatives as useful uro-selective a1a adrenoceptor blockers |
| 01/12/2005 | EP1494989A2 Compounds that modulate ppar activity and methods for their preparation |
| 01/12/2005 | EP1165532B1 Antibacterial agents |
| 01/12/2005 | CN1564811A Acylsulfonamides as inhibitors of steroid sulfatase |
| 01/12/2005 | CN1562971A Radioactive rhenium-N-accessory ingredient of alkyl dinitrogen disulfide for curing liver cancer and preparation method |
| 01/12/2005 | CN1184204C Piperidine compounds for use as CCR-3 inhibitors |
| 01/11/2005 | US6841682 Prevent binding of adrenergenic receptors |
| 01/11/2005 | US6841668 Polyoxometalate catalysts for the preparation of sterically hindered N-substituted aryloxyamines |
| 01/11/2005 | US6841562 Treatment of gram positive and staphylococcic infections |
| 01/11/2005 | CA2192555C 2-acylaminopropanol compound and medicinal composition |
| 01/06/2005 | WO2005000845A2 Bicyclic derivatives as nk-1 and nk-2 antagonists |
| 01/06/2005 | WO2005000839A1 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/06/2005 | WO2005000826A1 Urea derivatives of piperazines and piperidines as fatty acid oxidation inhibitors |
| 01/06/2005 | WO2005000815A2 Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic m3 receptor |
| 01/06/2005 | WO2005000800A1 Cathepsin cysteine protease inhibitors |
| 01/06/2005 | WO2005000309A2 Chemical compounds |
| 01/06/2005 | WO2005000305A1 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake |
| 01/06/2005 | WO2003042177A8 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/06/2005 | WO2003039482A8 Polymorphs of fexofenadine base |
| 01/06/2005 | WO2003032912A9 Treatment of cns disorders using cns target modulators |
| 01/06/2005 | US20050004230 Retroviral protease inhibitors |
| 01/06/2005 | US20050004168 New substituted pyridine or piperidine compounds |
| 01/06/2005 | US20050004164 2-Cyanopropanoic acid amide and ester derivatives and methods of their use |
| 01/06/2005 | US20050004136 Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful as neurokinin receptor modulators |
| 01/06/2005 | US20050004086 Indene derivatives as pharmaceutical agents |